0001102942
false
0001102942
2023-09-11
2023-09-11
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT PURSUANT
TO
SECTION 13 or 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of report (Date of earliest event reported): September 11, 2023
InnovaQor,
Inc.
(Exact
Name of Registrant as Specified in Its Charter)
Nevada
(State
or Other Jurisdiction of Incorporation)
000-33191 |
|
84-0436055 |
(Commission
File Number) |
|
(I.R.S.
Employer Identification No.) |
400
South Australian Avenue, Suite 800, West Palm Beach,
Florida |
|
33401 |
(Address
of Principal Executive Offices) |
|
(Zip
Code) |
(561)
421-1900 |
(Registrant’s
Telephone Number, Including Area Code) |
(Former
Name or Former Address, if Changed Since Last Report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):
☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered under Section 12(b) of the Act:
Title
of each class |
|
Trading
Symbol |
|
Name
of each exchange on which registered |
None |
|
None |
|
None |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item
7.01. Regulation FD Disclosure
On
September 11, 2023, InnovaQor, Inc. (the “Company”) issued a press release announcing that Darrell Peterson, our Chief Executive
Officer, would be interviewed on Uptick Newswire’s “Stock Day” podcast with Matthew Dunehoo. A copy of the press
release is attached hereto as Exhibit 99.1 and a transcript of the interview is attached hereto as Exhibit 99.2.
The
information furnished pursuant to this Item 7.01, including Exhibits 99.1 and 99.2, shall not be deemed “filed” for purposes
of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities
of that section, and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933,
as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item
9.01. Financial Statements and Exhibits
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Date:
September 15, 2023 |
INNOVAQOR,
INC. |
|
|
|
|
By: |
/s/
Darrell Peterson |
|
|
Darrell Peterson |
|
|
Chief
Executive Officer |
|
|
(principal
executive officer) |
Exhibit
99.1
![](https://www.sec.gov/Archives/edgar/data/1102942/000149315223032777/ex99-1_001.jpg)
INNOVAQOR,
INC. PROVIDES UPDATE AND CONFIRMS DEVELOPMENT OF NEW PRODUCT
WEST
PALM BEACH, Fla. (September 11, 2023) — InnovaQor, Inc. (OTC: INQR) Chief Executive Officer, Darrell Peterson recently joined Stock
Day host Matthew Dunehoo to provide an update and confirm the development of a new product, Curallo.
Dunehoo
began the interview by asking Peterson to remind his listeners about what InnovaQor does. Peterson provided a brief summary of the healthcare
specific software solutions the Company offers, and reminded the audience that these software solutions are fully developed, proven and
are marketed by the Company as a SAAS business model.
Dunehoo
then asked Peterson to describe the Company’s plan to build revenues. Peterson explained that the majority of current revenues
were generated from sales of the EHR product in the substance abuse sector and from the provision of IT services. He voiced his belief
that the Medical Mime EHR product was better than most of the competition and offered the fasted route to increased, profitable revenues.
He further explained that the cost basis could support a multiple of the current number of customers and confirmed the focus on adding
new customers. He went on to say that other Company products would receive an increased focus on marketing and would add value to the
new platform the Company was building.
Dunehoo
went on to ask Peterson for more information on this new product that had also been mentioned in recent filings and press releases. Peterson
stated that this was probably the most exciting thing that InnovaQor was working on and went on to describe Curallo, a new Medical Professionals
Communication Platform solely for the healthcare sector. He further explained that Curallo has been in development since April and that
a demonstration should be available in the next few weeks. He stated that Curallo would have a number of free and subscription features
but would start with a peer to peer communication platform for healthcare professionals and then expand to offer interactive services
for live conferences and training, and include recruitment matching for short and longer term needs in the healthcare sector. He finished
by confirming that a new website for Curallo had been launched at www.curallo.com to invite input from prospective users and to
provide updates on the status of the project.
Dunehoo
finished the interview by asking Peterson what message he would like the listeners to take away from today’s show. Peterson responded
by confirming that InnovaQor had a significant foundation to build from and repeated his belief that Curallo could create an opportunity
for unlimited growth over the next few years. He ended the interview by confirming the Company’s ambition to list on a recognized
stock exchange at some time in the future.
To
hear Darrell Peterson’s entire interview follow the link to the podcast here:
https://audioboom.com/posts/8364992-innovaqor-inc-inqr-is-featured-on-the-stock-day-podcast
For
further information on InnovaQor, Inc., please visit www.innovaqor.com
About
InnovaQor, Inc.
InnovaQor
delivers innovative technology and software solutions for the medical sector and intends to build a communication platform specifically
for the medical sector, which will facilitate communication and collaboration between peers and allow the addition of revenue generating
bolt on offers, including existing solutions and a new recruitment matching product for the healthcare sector.
Forward-Looking
Statements
This
press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States
Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations and, consequently, you should not rely
on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,”
“budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,”
“will,” “could,” “should,” “believes,” “predicts,” “potential,”
“continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements
involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Additional
information concerning these and other risk factors are contained in the Company’s most recent filings with the Securities and
Exchange Commission. The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as
of the date made. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions
to any forward-looking statements to reflect any change in their expectations or any change in events, conditions or circumstances on
which any such statement is based, except as required by law.
Contact:
Gerard
Dab
561 421 1905
press@innovaqor.com
Exhibit 99.2
InnovaQor, Inc. (INQR) Interview
CEO Darrell Peterson – Uptick News –
September 2023
Speakers: Matthew Dunehoo and Darrell Peterson
Dunehoo: On today’s show we are talking
to a Company that has been on before, but today we are speaking to a new CEO for the first time since he assumed the role back in May.
The Company is InnovaQor, Inc., that trades on the OTC market under the trading symbol INQR. InnovaQor creates innovative technology solutions
that allow medical providers and facilities to effectively enhance their business and processes while protecting their assets and patient
data. The new CEO of the Company is Darrell Peterson. Darrell, welcome, onto our show. We look forward to you giving us an update for
InnovaQor and hearing your plans for the future.
Peterson: Thank you Mathew. It is a pleasure
to be on your show and to have the opportunity to provide some updates for your audience and our shareholders.
Dunehoo: I know they are ready to hear it so
I will go ahead and get right to it. First question, it’s been a while since the Company was last on the show. Would you please
take a minute and remind us about exactly what InnovaQor does?
Peterson: Of course. InnovaQor owns a number
of software solutions specific to the healthcare sector. These solutions include Electronic Health Records software focused on the substance
abuse sector, diagnostics interpretation and laboratory information software as well as data mining and interpretation to assist healthcare
facilities manage and improve efficiencies and cash flow. These solutions had millions of dollars invested in them, are fully developed
and proven, and are marketed by us as a SAAS model.
Dunehoo: Excellent, thank you very much. That
is an exciting suite of solutions in a very high growth sector as our audience will clearly understand. Can you tell us about your plans
to build revenues?
Peterson: The majority of our revenue is currently
generated from our Medical Mime product and provision of IT services. Medical Mime is an EHR product that is currently focused on the
substance abuse sector. We are confident this solution is comparable, and better, with most of our competition and I believe this product
offers the fastest route to increased and profitable revenues at this time. Our current cost basis can support a multiple of the number
of customers we currently serve and we are currently focusing on adding new customers. Our other products also have an exciting opportunity
for increased revenues and will have an increased focus on marketing going forward. All of our products will create an added value and
be marketed as a component to an exciting new platform that we are building.
Dunehoo: You mentioned this new platform. I
have seen your filings and press releases mentioning your plans to build this new platform. Now is the time when you can tell us more
about this new platform, please.
Peterson: Matthew, this is probably the most
exciting thing InnovaQor is working on. We have started to build a new platform under the brand name Curallo. It is a Medical Professional’s
Network Communication Platform solely for the healthcare sector and will have a number of free and subscription features. We have engaged
an external software development team back in April and expect to have a basic demonstration of our platform available in the next few
weeks. We will start with a peer to peer communication platform for healthcare professionals and include an interactive service for live
conferences and training as well as a recruitment matching service for short or longer-term needs. We have just launched a website at
curallo.com to invite input from prospective users and will keep that updated with our progress and launch details.
Dunehoo: That’s good to know. It sounds
exciting. So much going on. You’ve clearly got a busy time ahead. As we finish up today’s show can I ask you what message
you would like our listeners to take away from the show?
Peterson: I would like your audience to understand
that we have a significant foundation formed and secured, and have embarked on a project that could deliver unlimited opportunity for
growth in the next few years. We are currently a fully reporting company listed on the OTC but have an ambition to become listed on a
recognized stock exchange at the appropriate time in the future. Thank you for the opportunity to tell your listeners about InnovaQor.
Dunehoo: Absolutely Darrell, thanks for being
with us today. My guest has been InnovaQor CEO, Darrell Peterson. Again, they trade on the OTC market under the trading symbol INQR. Darrell
I’d like to thank you so much for coming on the show, with so much coming down the pike I hope to have you back with us very soon
for an update.
Peterson: Very well. Thank you and thanks to
your audience.
v3.23.2
X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
+ Details
Name: |
dei_AmendmentFlag |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
+ Details
Name: |
dei_DocumentPeriodEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:dateItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
+ Details
Name: |
dei_DocumentType |
Namespace Prefix: |
dei_ |
Data Type: |
dei:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
+ References
+ Details
Name: |
dei_EntityAddressAddressLine1 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 2 such as Street or Suite number
+ References
+ Details
Name: |
dei_EntityAddressAddressLine2 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
+ References
+ Details
Name: |
dei_EntityAddressCityOrTown |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCode for the postal or zip code
+ References
+ Details
Name: |
dei_EntityAddressPostalZipCode |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the state or province.
+ References
+ Details
Name: |
dei_EntityAddressStateOrProvince |
Namespace Prefix: |
dei_ |
Data Type: |
dei:stateOrProvinceItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate if registrant meets the emerging growth company criteria.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityEmergingGrowthCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
+ Details
Name: |
dei_EntityFileNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fileNumberItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
+ References
+ Details
Name: |
dei_EntityIncorporationStateCountryCode |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarStateCountryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityTaxIdentificationNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:employerIdItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLocal phone number for entity.
+ References
+ Details
Name: |
dei_LocalPhoneNumber |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 13e -Subsection 4c
+ Details
Name: |
dei_PreCommencementIssuerTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14d -Subsection 2b
+ Details
Name: |
dei_PreCommencementTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Section 14a -Number 240 -Subsection 12
+ Details
Name: |
dei_SolicitingMaterial |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 -Section 425
+ Details
Name: |
dei_WrittenCommunications |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
VisualMED Clinical Solut... (PK) (USOTC:VMCS)
Historical Stock Chart
From Jul 2024 to Aug 2024
VisualMED Clinical Solut... (PK) (USOTC:VMCS)
Historical Stock Chart
From Aug 2023 to Aug 2024